IRCT20120618010057N2招募中2 期
The effect of addition of low dose abiraterone to the ADT+RT in local recurrent prostate cancers after previous surgery, in terms of biochemical recurrence
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Male
入选标准
- •Prostate cancer patients with local recurrence after radical prostatectomy
排除标准
- •Hormone resistant
研究者
相似试验
招募中
2 期
Comparison of low dose vs standard dose abiraterone in prostate cancer patientsProstate cancer.Malignant neoplasm of prostateIRCT20120618010057N3Shahid Beheshti University of Medical Sciences64
尚未招募
不适用
To determine the benefit of reduced dose abiraterone as compared to Standard dose in Metastatic Prostate Cancer Patients.CTRI/2020/08/026967Tata Memorial Centre
已完成
1 期
MAdCaP: MDM2 inhibition and Abiraterone in Carcinoma of the ProstateMalignant neoplasm of prostateCancerProstate cancerISRCTN38949950HS Greater Glasgow and Clyde (UK)132
进行中（未招募）
1 期
A phase I/randomised phase II trial of abiraterone acetate with or without RO5503781 in patients with mCRCP who have not previously received docetaxel.CancerEUCTR2013-002014-13-GBHS greater Glasgow and Clyde132
招募中
不适用
A Clinical trial to study the effect of the drug Atropine in patients with myopia to slow down its progression.CTRI/2022/09/045977Comtrust Charitable trust Eye Hospital